Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Russo

Showing results (261-270 of 348) with videos related to

Pageof 35
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|July 13, 2017
Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre ExperienceMichele Malagola, Bendetta Rambaldi, Giuseppe Ravizzola, et al.
Cell Biology International|March 1, 2025
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically EquivalentAlessia Cavalleri, Besjana Xhahysa, Silvia Mutti, et al.
Cancer|January 3, 2014
Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvementSimona Soverini, Caterina De Benedittis, Cristina Papayannidis, et al.
Cells|September 23, 2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway InhibitorsSilvia Codenotti, Daniela Zizioli, Luca Mignani, et al.
Blood|August 21, 2004
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemiaMichele Baccarani, Giovanni Martinelli, Gianantonio Rosti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2025
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 TrialMohamad Mohty, Gerard Socié, Jeff Szer, et al.
Plos One|February 24, 2017
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells)Simone Perucca, Andrea Di Palma, Pier Paolo Piccaluga, et al.
The EMBO Journal|December 29, 2017
Glycosphingolipid metabolic reprogramming drives neural differentiationDomenico Russo, Floriana Della Ragione, Riccardo Rizzo, et al.
Current Osteoporosis Reports|September 11, 2017
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone HomingMichele Moschetta, Yawara Kawano, Antonio Sacco, et al.
Head & Neck|October 4, 2024
Development of a Preclinical Double Model of Mandibular Irradiated Bone and Osteoradionecrosis in New Zealand RabbitsAlessandra Ruaro, Stefano Taboni, Harley H L Chan, et al.
Pageof 35

Showing results (261-270 of 348) with videos related to

Sort By:
Pageof 35
Mediterranean Journal of Hematology and Infectious Diseases|July 13, 2017
Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre ExperienceMichele Malagola, Bendetta Rambaldi, Giuseppe Ravizzola, et al.
Cell Biology International|March 1, 2025
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically EquivalentAlessia Cavalleri, Besjana Xhahysa, Silvia Mutti, et al.
Cancer|January 3, 2014
Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvementSimona Soverini, Caterina De Benedittis, Cristina Papayannidis, et al.
Cells|September 23, 2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway InhibitorsSilvia Codenotti, Daniela Zizioli, Luca Mignani, et al.
Blood|August 21, 2004
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemiaMichele Baccarani, Giovanni Martinelli, Gianantonio Rosti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2025
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 TrialMohamad Mohty, Gerard Socié, Jeff Szer, et al.
Plos One|February 24, 2017
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells)Simone Perucca, Andrea Di Palma, Pier Paolo Piccaluga, et al.
The EMBO Journal|December 29, 2017
Glycosphingolipid metabolic reprogramming drives neural differentiationDomenico Russo, Floriana Della Ragione, Riccardo Rizzo, et al.
Current Osteoporosis Reports|September 11, 2017
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone HomingMichele Moschetta, Yawara Kawano, Antonio Sacco, et al.
Head & Neck|October 4, 2024
Development of a Preclinical Double Model of Mandibular Irradiated Bone and Osteoradionecrosis in New Zealand RabbitsAlessandra Ruaro, Stefano Taboni, Harley H L Chan, et al.
Pageof 35